home / stock / vaxx / vaxx news

VAXX News and Press, Vaxxinity Inc. From 08/01/22

Stock Information
Company Name: Vaxxinity Inc.
Stock Symbol: VAXX
Market: OTC
Website: vaxxinity.com
Menu
VAXX VAXX Quote VAXX Short VAXX News VAXX Articles VAXX Message Board
Get VAXX Alerts

News, Short Squeeze, Breakout and More Instantly...
VAXX - Vaxxinity Presents Preclinical Data on Tau Vaccine Candidates at the 2022 Alzheimer's Association International Conference (AAIC)

DALLAS, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, presented new preclinical data on vaccine candidates targeting aberrant forms of the Tau protein for Alzheimer’s disease (...
VAXX - Vaxxinity CEO Mei Mei Hu Speaking at White House Summit on the Future of COVID-19 Vaccines

Summit is taking place July 26, 2022 from 11:00 AM ET – 3:15 PM ET The White House Summit on the Future of COVID-19 Vaccines live webcast can be accessed here DALLAS, July 25, 2022 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX ) Chief Executive Offic...

VAXX - Bone Biologics, Akero top healthcare gainers; AC Immune, Arcellx lead losers' pack

Gainers: Bone Biologics (BBLG) +13%. Akero Therapeutics AKRO +10%. Biotricity (BTCY) +9%. Jasper Therapeutics (JSPR) +7%. Burning Rock Biotech (BNR) +6%. Losers: AC Immune ACIU -17%. Arcellx ACLX -17%. SOPHiA GENETICS (SOPH) -16%. AirSculpt Te...

VAXX - Vaxxinity to Participate at the Jefferies Healthcare Conference

DALLAS, June 02, 2022 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, today announced that Mei Mei Hu, President and Chief Executive Officer of Vaxxinity, will participate in a fireside chat at the J...
VAXX - FUV, ATNF and LOV among mid-day movers

Gainers: Tonix Pharmaceuticals Holding (TNXP) +60%. Helius Medical Technologies (HSDT) +40%. View (VIEW) +42%. Spark Networks (LOV) +32%. Regencell Bioscience Holdings (RGC) +21%. 180 Life Sciences (ATNF) +20%. Evelo Biosciences (EVLO) +17%. NeuroOne Medical Technologies Corporation (NMTC) +1...

VAXX - Vaxxinity GAAP EPS of -$0.47, revenue of $0.17M

Vaxxinity press release (NASDAQ:VAXX): Q1 GAAP EPS of -$0.47. Revenue of $0.17M. For further details see: Vaxxinity GAAP EPS of -$0.47, revenue of $0.17M

VAXX - Vaxxinity Reports First Quarter 2022 Financial Results and Provides Corporate Updates

DALLAS, May 09, 2022 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, today reported financial results for the first quarter ended March 31, 2022. “Vaxxinity has laid the groundwork to ha...
VAXX - Stocks To Watch: Peloton, Rivian And Under Armour Look For Comebacks

Get ahead of the market by subscribing to Seeking Alpha's Stocks to Watch, a preview of key events scheduled for the coming week. The newsletter keeps you informed of the biggest stories set to make headlines, including upcoming IPOs, investor days, earnings reports and conference presentatio...

VAXX - Vaxxinity to Participate at the Bank of America Securities 2022 Healthcare Conference

DALLAS, May 05, 2022 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, today announced that Mei Mei Hu, President and Chief Executive Officer of Vaxxinity, will participate in a fireside chat at the Ba...

VAXX - The Estee Lauder Companies, Rockwell Automation, Logitech International among premarket losers' pack

Spero Therapeutics (SPRO) -52% after announcing new strategic direction focusing on advancing promising clinical-stage pipeline. Chegg (CHGG) -40% on Q1 earnings release. Galmed Pharmaceuticals (GLMD) -19% on Q4 earnings release. Better Therapeutics (BTTX) -16%. Haywa...
Previous 10 Next 10